We are live on ! Find out more
AVTX icon

Avalo Therapeutics
AVTX

16 hedge funds and large institutions have $53.6M invested in Avalo Therapeutics in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 1

278% more capital invested

Capital invested by funds: $14.2M → $53.6M (+$39.4M)

167% more funds holding

Funds holding: 6 → 16 (+10)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

Holders
16
Holders Change
+10
Holders Change %
+166.67%
% of All Funds
0.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$388K
2
VF
Virtu Financial
New York
+$263K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$90.4K
4
AC
Armistice Capital
New York
+$73.2K
5
Citadel Advisors
Citadel Advisors
Florida
+$38.8K

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$506K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$51.4M +$73.2K +17 +0.3%
BCM
2
Bridgeway Capital Management
Texas
$826K +$388K +90 New
VF
3
Virtu Financial
New York
$560K +$263K +61 New
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$194K +$90.4K +21 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$182K +$4.31K +1 +5%
Citadel Advisors
6
Citadel Advisors
Florida
$84K +$38.8K +9 New
RJFSA
7
Raymond James Financial Services Advisors
Florida
$74K +$34.5K +8 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$62K +$30.1K +7 New
BFM
9
Boothbay Fund Management
New York
$54K +$25.8K +6 New
Commonwealth Equity Services
10
Commonwealth Equity Services
Massachusetts
$42K – – –
Northern Trust
11
Northern Trust
Illinois
$36K +$17.2K +4 New
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
$32K +$12.9K +3 New
Morgan Stanley
13
Morgan Stanley
New York
$27K +$12.9K +3 New
BlackRock
14
BlackRock
New York
$12K – – –
TWA
15
TCI Wealth Advisors
Arizona
$10K – – –
UBS Group
16
UBS Group
Switzerland
$7K +$4.31K +1 New
AG
17
Advisor Group
Arizona
$3K – – –
AWM
18
Avior Wealth Management
Nebraska
$3K – – –
NMC
19
NEA Management Company
Maryland
– -$506K -207 Closed

AVTX Hedge Fund Activity: Q4 2017 in Review

16 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Avalo Therapeutics (AVTX) for Q4 2017, worth a combined $53.6M — up 278% from $14.2M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AVTX positions and 1 closed out — a net gain of 10 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $388K. The largest seller was NEA Management Company, exiting entirely with an estimated $506K sold.

  • 16 institutional investors held Avalo Therapeutics (AVTX) as of Q4 2017, up from 6 in Q3 2017.
  • Funds reported $53.6M of Avalo Therapeutics stock for Q4 2017, up 278% quarter-over-quarter.
  • 11 funds opened new Avalo Therapeutics positions in Q4 2017 and 1 closed out, a net change of +10 holders.
  • The largest Avalo Therapeutics buyer in Q4 2017 was Bridgeway Capital Management, an estimated $388K added.
  • The largest Avalo Therapeutics seller in Q4 2017 was NEA Management Company, an estimated $506K sold.

Based on aggregated 13F filings for Q4 2017.